Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Alessandro Tozzi, Michela Tantucci, Saverio Marchi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
Nolwazi Z. Gcwensa, Drèson L. Russell, Rita M. Cowell, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 71
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
Paola Imbriani, Giuseppina Martella, Paola Bonsi, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105851-105851
Open Access | Times Cited: 43
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Ludovica Iovino, Veronica Giusti, Francesca Pischedda, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 1, pp. 81-106
Open Access | Times Cited: 39
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Marika Alborghetti, Ferdinando Nicoletti
Current Neuropharmacology (2018) Vol. 17, Iss. 9, pp. 861-873
Open Access | Times Cited: 81
Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations
Chuyu Chen, Giulia Soto, Vasin Dumrongprechachan, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 49
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
Isabella Russo, Giulietta Di Benedetto, Alice Kaganovich, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 41
Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization
Elise Wouters, Adrián Ricarte Marín, James A. R. Dalton, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 31
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
Naila Kuhlmann, Austen J. Milnerwood
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 29
Compartmentalized Signaling in Aging and Neurodegeneration
Giulietta Di Benedetto, Liliana F. Iannucci, Nicoletta C. Surdo, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 464-464
Open Access | Times Cited: 27
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2025)
Open Access
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
Daniela Mercatelli, Alberto Brugnoli, Anna Maio, et al.
Neurobiology of Disease (2025), pp. 106881-106881
Open Access
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons
Chuyu Chen, Meghan Masotti, Nathaniel Shepard, et al.
Molecular Psychiatry (2025)
Open Access
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
eLife (2025) Vol. 13
Open Access
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Alessandro Tozzi, Valentina Durante, Guendalina Bastioli, et al.
Neurobiology of Disease (2018) Vol. 118, pp. 1-8
Open Access | Times Cited: 28
Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling
Akanksha Mishra, Sarika Singh, Virendra Tiwari, et al.
Neurochemistry International (2019) Vol. 129, pp. 104463-104463
Closed Access | Times Cited: 27
Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
Giulia Lamonaca, Mattia Volta
Cells (2020) Vol. 9, Iss. 5, pp. 1115-1115
Open Access | Times Cited: 24
R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations
Harry S. Xenias, Chuyu Chen, Shuo Kang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 16
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway
Federica Albanese, Chiara Domenicale, Mattia Volta, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 1, pp. 621-632
Closed Access | Times Cited: 15
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019Smodel of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2024)
Open Access | Times Cited: 3
Structural Changes Observed in the Piriform Cortex in a Rat Model of Pre-motor Parkinson’s Disease
Marco Sancandi, Emma Victoria Schul, Georgia Economides, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 21
Effect of the Flavonoid Rutin on the Modulation of the Myenteric Plexuses in an Experimental Model of Parkinson’s Disease
Lívia Bacelar de Jesus, Annyta Fernandes Frota, Fillipe M. de Araújo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1037-1037
Open Access | Times Cited: 2
Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans
Ann-Kathrin Weishaupt, Lysann Ruecker, Torben Meiners, et al.
Toxicological Sciences (2024) Vol. 201, Iss. 2, pp. 254-262
Closed Access | Times Cited: 2
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
Andrea Mancini, Petra Mazzocchetti, Miriam Sciaccaluga, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top